U.S. Wireless Telecom Stock News

Why Marqeta Stock Is Back On Investors’ Radar Marqeta (MQ) drew fresh attention after a 4.5% move higher, as investors rotated from AI chip stocks into enterprise software and payments platforms tied to AI monetization. See our latest analysis for Marqeta. Beyond today’s move, Marqeta’s share price return shows a short burst of momentum, with a 7-day share price return of 12.5% and a 30-day share price return of 11.63%, set against a year-to-date share price decline of 6.41% and a 1-year...

Hyatt Hotels (NYSE:H) and Air Canada’s Aeroplan launched a new partnership that links their loyalty programs. World of Hyatt and Aeroplan members can now connect accounts to broaden reward earning and redemption options. The collaboration introduces new ways to progress toward elite status across both travel programs. Hyatt Hotels, trading at $191.0, is adding this airline tie up at a time when the stock is up 30.5% over the past year and 149.6% over five years. The new link with Aeroplan...

In recent days, Seagate Technology Holdings has been pulled lower as a broad selloff in AI and memory chip names followed concerns about cloud spending, inventory buildup, and macro risks such as inflation and Middle East tensions. At the same time, enthusiasm around Seagate’s HAMR‑based Mozaic 4+ drives and its role in AI and cloud storage shows how sector-wide sentiment can temporarily mask company‑specific strengths. With sector worries about cloud capex and inventory now front of mind,...

Equity Residential recently declared a dividend and is preparing to report earnings, focusing investor attention on its apartment portfolio, cash flow, and operating fundamentals. This renewed scrutiny puts a spotlight on how occupancy, rental pricing, resident retention, and financing conditions could influence the REIT’s income profile and perceived resilience. Next, we’ll examine how this increased focus on occupancy and rental pricing interacts with Equity Residential’s existing...

Mueller Water Products has delivered an 80.6% total return over the past five years, yet its current share price of US$24.70 still screens as cheap against an intrinsic value estimate from a Discounted Cash Flow (DCF) model and traditional market multiples. That combination puts the focus on whether the recent moderation in shorter term returns reflects a pause in a longer rerating or a sign that the value case is already well understood. Over five years, Mueller Water Products has returned...

Graham stock has logged a very strong run over the last several years, yet its latest valuation checks suggest the shares are now pricing in a lot of good news rather than standing out as a clear bargain. Over the past 5 years, Graham has delivered a very large total return of about 7x, which sets a high bar for any further upside case. Recent growth momentum and raised expectations for future revenue may support the current share price, but any setback in demand or profitability could...

In the lead‑up to its 21 July earnings release, The Charles Schwab Corporation has drawn attention as Wall Street anticipated year‑over‑year earnings growth on higher revenues for the June 2026 quarter, supported by a more optimistic analyst consensus. An interesting angle is that the Most Accurate Estimate recently moved above the broader Zacks Consensus Estimate, highlighting a late shift in analyst expectations that could influence how investors interpret Schwab’s earnings power. We’ll...

AtaiBeckley stock has delivered a 148.7% return over the last three years, yet its valuation checks flag the shares as expensive rather than a clear bargain. A 148.7% three year return puts AtaiBeckley firmly in the spotlight and raises the bar for what future progress needs to justify the current share price. The advancing psychedelic pipeline, including BPL-003 in Phase 3 and VLS-01 in Phase 2b for treatment resistant depression, can support high expectations, while takeover speculation...

Gap stock has pulled back recently but, on a three year view, the share price is still far ahead of where it was, and the current valuation work suggests the market may be assigning a discount relative to an intrinsic value estimate based on a Discounted Cash Flow (DCF) approach and to earnings based multiples. Gap has delivered a 139.2% return over the past three years, which puts the recent weakness into context as a move within a much larger recovery. For valuation, the key swing factor...

Elevance Health (ELV) has completed a long running share repurchase program as investors prepare for an anticipated year over year decline in Q2 earnings and revenue and monitor new institutional interest. See our latest analysis for Elevance Health. At a share price of $426.79, Elevance Health has seen firm upward momentum recently, with a 30 day share price return of 5.62% and a 90 day share price return of 37.15%, while the 1 year total shareholder return of 29.61% sits well ahead of its 3...

The U.S. Small Business Administration recently formalized a new phase of its anti-fraud initiative, rolling out Palantir Technologies’ software to help uncover and prosecute fraud across pandemic-era small business relief programs, while fresh collaborations with Rackspace, SNP, and GNP Seguros extend Palantir’s AI platforms into tightly regulated sectors worldwide. Together, these moves highlight Palantir’s push to become core infrastructure for compliant, operational AI where data...

Helium export curbs put Linde (LIN) in focus Restrictions on helium exports from China, Russia, and Qatar have tightened global supply for semiconductor and AI hardware producers, putting Linde (LIN) in the spotlight as investors reassess helium-exposed stocks. See our latest analysis for Linde. Linde’s share price at US$522.54 has eased in the last week, with a 7 day share price return of 2.92% and a relatively steady 90 day share price return of 4.94%, while the 5 year total shareholder...

McKesson (NYSE:MCK) released its Fiscal Year 2026 Impact Report, outlining progress on sustainability, healthcare delivery, and stakeholder engagement. The report provides updated details on environmental goals, community support programs, and partnerships with healthcare providers. It offers investors and other stakeholders a consolidated view of how the company is approaching ESG topics alongside its core distribution and services business. McKesson enters this update with its stock at...

Check Point Software Technologies stock has had a tough year, with a steep share price decline set against valuation work that points to the shares trading below an intrinsic value estimate based on a Discounted Cash Flow (DCF) approach and supported by market multiples that also lean cheap. Over the past 12 months, Check Point Software Technologies is down 37.4%, which means any sign of undervaluation matters more for investors trying to assess if sentiment has swung too far. Recent reports...

Cooling US inflation data and sharply lower producer and gasoline prices are reshaping expectations for borrowing costs and consumer budgets, while tensions in the Strait of Hormuz keep the energy outlook uncertain. That mix can reward some U.S. Domestic Consumer Discretionary Stocks exposed to these trends and leave others facing tougher decisions on pricing and costs. This article focuses on three stocks from the screener that appear positively exposed to the recent PPI and CPI moves,...

Why MakeMyTrip Stock Is Back On Investors’ Radar MakeMyTrip (MMYT) has drawn attention after its stock declined 2.33% in the latest session despite broader market gains. Investors are now focused on an upcoming earnings report that is expected to show $0.10 per share. See our latest analysis for MakeMyTrip. The recent 1 day share price decline of 2.33% and 7 day drop of 5.03% come after a 30 day share price return of 29.20%. The 1 year total shareholder return is down 40.06%, while the 5 year...

Why investors are reassessing Humana stock now Recent debate over Humana (HUM) centers on conflicting views of its valuation, with tighter Medicare oversight and compliance concerns set against models that point to undervaluation based on projected future cash flow. See our latest analysis for Humana. Humana’s recent share price strength, including a 7.26% 1 month share price return and 53.80% year to date share price return to about $406.77, contrasts with weaker 3 and 5 year total...

Lam Research stock has delivered a very large 5 year gain, yet the current valuation checks suggest it no longer screens as a clear bargain, with recent swings in sector sentiment adding another layer of uncertainty for investors trying to judge what the current price is baking in. Lam Research has returned about 5x over the past 5 years, which raises the bar for any further upside to be justified by future cash flows and earnings power. Strong demand for semiconductor equipment tied to AI...

On 9 July 2026, Otsuka ICU Medical LLC announced plans to invest over US$500 million to expand IV solutions manufacturing in Austin, Texas, adding a new 500,000-square-foot facility and upgrading its existing 700,000-square-foot site to support non-DEHP containers and future innovation. This large-scale build-out aims to improve North American supply resiliency for IV solutions while aligning the joint venture with evolving non-DEHP legislation and regulatory expectations. Next, we’ll...

Enovix Corporation recently appointed Dr. Michael Vyvoda, a former Apple Director of Product Operations with extensive manufacturing experience, as Chief Operating Officer, consolidating global manufacturing, supply chain and operations engineering under his leadership. His background in scaling AirPods to high-volume production and driving cost reductions could be especially relevant as Enovix builds out facilities in Malaysia and Korea with R&D support from India. We’ll now examine how...

SEI Investments (SEIC) drew fresh attention after launching the SEI QiM U.S. Equity Factor Allocation Active ETF, a core U.S. equity product built on its quantitative factor allocation research and risk framework. See our latest analysis for SEI Investments. SEI Investments shares trade at $94.89 after a slight pullback over the past day and week, although a 6.14% 1 month share price return and 18.60% 3 month share price return suggest momentum has been building, supported by a 5.38% 1 year...

Nuclear energy stocks sit at the crossroads of power security, inflation concerns and shifting interest rate expectations, as investors look for assets tied to essential infrastructure and long term energy demand. With inflation signals mixed across the US, Europe and Asia, and sovereign yields moving on each new data release, some investors are revisiting nuclear as a potential source of more predictable cash flows within the wider energy mix. This Nuclear Energy Stocks screener highlights...

Cincinnati Financial recently attracted attention as analysts highlighted its history of beating earnings expectations and pointed to indicators suggesting another potential earnings beat in its upcoming report, even as consensus sees only modest book value per share growth ahead. This mix of strong recent execution against estimates and relatively muted expectations for future balance sheet expansion raises questions about how much earnings surprise potential remains embedded in the...

Short seller report alleges Bloom Energy relies on undisclosed Chinese sources for scandium used in its fuel cells. Bloom Energy strongly denies the claims, emphasizing its view of supply chain integrity and compliance. Analyst sentiment remains broadly supportive, with bullish views persisting as AI data center demand hits record levels. Bloom Energy (NYSE:BE) is back in focus after this latest supply chain dispute, coming at a time when the stock has already moved sharply over the past...